Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 220.466B	--
Feb 13, 2025	2025/Q3	227.745B / 226.901B	--
Nov 11, 2024	2025/Q2	213.303B / 209.930B	--
Aug 9, 2024	2025/Q1	200.819B / 203.050B	--
May 13, 2024	2024/Q4	195.584B / 193.571B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 220.466B--

Feb 13, 20252025/Q3227.745B / 226.901B--

Nov 11, 20242025/Q2213.303B / 209.930B--

Aug 9, 20242025/Q1200.819B / 203.050B--

May 13, 20242024/Q4195.584B / 193.571B--

Unlock Free Earnings Estimates

Open Account

Senko Group Holdings Earnings Reports

Senko Group Holdings: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Feb 13 01:30 ET

Senko Group Holdings: Half Year Report - Term 108 (2024/04/01 - 2025/03/31)

Nov 13, 2024 23:00 ET

Senko Group Holdings: Confirmation letter

Nov 13, 2024 23:00 ET

Senko Group Holdings: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

Nov 11, 2024 02:30 ET

Symbol Price % Chg

Kyorin Pharmaceutical

4569

1677 +21.79%